During the past decade, Iowa Cancer Specialists conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Cancer Specialists" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Cancer Specialists" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Cancer Specialists" are "Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Iowa Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Iowa Cancer Specialists" are "Drug" (24 trials), "Other" (19 trials), "Biological" (11 trials), "Procedure" (11 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (8 trials), "Pembrolizumab" (7 trials), "Quality-of-Life Assessment" (7 trials), "Cisplatin" (6 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Cancer Specialists" are 30 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Iowa Cancer Specialists". undefined are not yet recruiting, 12 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Iowa Cancer Specialists, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Cancer Specialists, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".